Lions Gate Shares Following Merger and Private Placement
December 09 2003 - 5:23PM
PR Newswire (US)
Lions Gate Shares Following Merger and Private Placement MAHWAH,
N.J., Dec. 9 /PRNewswire-FirstCall/ -- Lions Gate Investment
Limited (Lions Gate) (LGIV.OB) announced today that immediately
following the closing of the merger and the first tranche of the
private placement described in the company press release of this
same date, Lions Gate had outstanding 37,661,650 shares of common
stock, warrants to purchase 16,093,770 shares of Lions Gate common
stock, and stock options to purchase 1,472,000 shares of Lions Gate
common stock. Forward Looking Statements This release contains
certain "forward-looking statements," relating to the business of
DOBI Medical, which can be identified by the use of forward-looking
terminology such as "believes," "expects," or similar expressions.
Such forward looking statements involve known and unknown risks and
uncertainties, including uncertainties relating to product
development, regulatory actions or delays, the ability to obtain or
maintain patent or other proprietary intellectual property
protection, market acceptance, physician acceptance, third party
reimbursement, future capital requirements, competition in general
and other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Certain of these risks and uncertainties are
or will be described in greater detail in our filings with the
Securities and Exchange Commission. DOBI Medical Systems is under
no obligation (and expressly disclaims any such obligation) to
update or alter its forward-looking statements whether as a result
of new information, future events or otherwise. DATASOURCE: DOBI
Medical Systems, Inc. CONTACT: Michael Jorgenson, Executive Vice
President of DOBI Medical Systems, Inc., +1-201-760-6464, or Fax,
+1-201-760-8860 Web site: http://www.dobimedical.com/
Copyright